AVINGER INC (AVGR)
US0537348775 - Common Stock
Overall AVGR gets a fundamental rating of 1 out of 10. We evaluated AVGR against 193 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of AVGR have multiple concerns. AVGR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
AVGR had negative earnings in the past year.
In the past year AVGR has reported a negative cash flow from operations.
AVGR had negative earnings in each of the past 5 years.
AVGR had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
AVGR has a worse Return On Assets (-133.00%) than 89.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -133% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-106.27%
ROA(5y)-96.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 26.31%, AVGR is not doing good in the industry: 76.56% of the companies in the same industry are doing better.
AVGR's Gross Margin has improved in the last couple of years.
AVGR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 26.31% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.35%
GM growth 5Y8.48%
2. Health
2.1 Basic Checks
AVGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AVGR has more shares outstanding
Compared to 5 years ago, AVGR has more shares outstanding
AVGR has a worse debt/assets ratio than last year.
2.2 Solvency
AVGR has an Altman-Z score of -46.63. This is a bad value and indicates that AVGR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -46.63, AVGR is not doing good in the industry: 94.79% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -46.63 |
ROIC/WACCN/A
WACC7.84%
2.3 Liquidity
A Current Ratio of 0.63 indicates that AVGR may have some problems paying its short term obligations.
AVGR's Current ratio of 0.63 is on the low side compared to the rest of the industry. AVGR is outperformed by 95.31% of its industry peers.
A Quick Ratio of 0.36 indicates that AVGR may have some problems paying its short term obligations.
AVGR's Quick ratio of 0.36 is on the low side compared to the rest of the industry. AVGR is outperformed by 96.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.36 |
3. Growth
3.1 Past
AVGR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.67%, which is quite impressive.
Looking at the last year, AVGR shows a decrease in Revenue. The Revenue has decreased by -7.42% in the last year.
AVGR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.69% yearly.
EPS 1Y (TTM)62.67%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q62.5%
Revenue 1Y (TTM)-7.42%
Revenue growth 3Y-4.41%
Revenue growth 5Y-0.69%
Revenue growth Q2Q-4.7%
3.2 Future
AVGR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.75% yearly.
Based on estimates for the next years, AVGR will show a very strong growth in Revenue. The Revenue will grow by 27.27% on average per year.
EPS Next Y-142.34%
EPS Next 2Y27.43%
EPS Next 3Y20.75%
EPS Next 5YN/A
Revenue Next Year36.55%
Revenue Next 2Y29.82%
Revenue Next 3Y29.14%
Revenue Next 5Y27.27%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AVGR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AVGR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
AVGR's earnings are expected to grow with 20.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.43%
EPS Next 3Y20.75%
5. Dividend
5.1 Amount
No dividends for AVGR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AVINGER INC
NASDAQ:AVGR (5/3/2024, 7:00:01 PM)
After market: 3.7901 -0.11 (-2.82%)3.9
+0.06 (+1.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.63M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -133% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 26.31% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.36 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)62.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-142.34%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-7.42%
Revenue growth 3Y-4.41%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y